Vildagliptin (LAF-237) - Moligand™, 10mM in DMSO , Dipeptidyl peptidase IV inhibitor, CAS No.274901-16-5, Dipeptidyl peptidase IV inhibitor

CAS: 274901-16-5 Cat. No.: V408745 分子式: C17H25N3O2 分子量: 303.4 EC番号: 630-410-0 PubChem CID: 6918537
注文可能
グレード&純度 Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. 10mM in DMSO
Synonyms
2-Pyrrolidinecarbonitrile, 1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)-
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
サイズ
USA
ドイツ (EU)*
価格
個数
1ml
V408745-1ml
2 在庫あり
—

$181.90

$265.90
保存 $84.00 (31.59%)
Enter a quantity for the sizes you want to add.

概要

Information

Vildagliptin (LAF-237) Vildagliptin (LAF-237) inhibits DPP−4 with IC50 of 2.3 nM.
In vitro

Vildagliptin is the most stable DPP-IV inhibitor, binding in the S1- and S2-catalytic sites of DPP-IV, possessing a P-1 site transition-state mimetic.

In vivo

Vildagliptin(orally dosed with 10 μmol/kg) is a potent, orally active inhibitor of plasma DPP-IV activity that provides increased levels of GLP-1 in an oral glucose tolerance test (OGTT) with Obese male Zucker rats. Vildagliptin orally dosed with 10 μmol/kg both significantly decreases glucose excursions and stimulates insulin secretion in Obese male Zucker rats. Maximum inhibition of plasma DPP-IV activity (95%) is observed approximately 2 hours postdose of Vildagliptin (1 μmol/kg, po) while >50% inhibition of DPP-IV is observed within 30 min postdose and persisted for >10 hours in normal Cynomolgus monkeys. Vildagliptin(60 mg/kg) increases pancreatic beta cell mass through enhanced beta cell replication and reduced apoptosis, and the increased beta cell mass is sustained for 12 days after vildagliptin washout. Vildagliptin administrated at doses of 10 mg/kg for 32 weeks protects nerve fiber loss in streptozotocin (STZ)-induced diabetic adult male Sprague Dawley rats.
Cell Data

cell lines:MCF7, NCI-H292, Colo-205, HT29, H358, H1703, BxPC3, A673, SW620, DU4475, HepG2 and Hepa-1, RKO 3T3/hulGF-IR and H292 cells

Concentrations:

Incubation Time:

Powder Purity:≥99%

仕様

同義語
2-Pyrrolidinecarbonitrile, 1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)-
仕様と純度
Moligand™, 10mM in DMSO
生化学的・生理学的メカニズム
Vildagliptin (LAF-237) inhibits DPP−4 with IC50 of 2.3 nM.
保管条件
Store at -80°C
入荷
Dry ice packs + Cold packs
この製品は冷冷この冷このこの製品の運送が必要です。地上およびその他の経済サービスは利用できません。
等級
Moligand™
アクションタイプ
ACTIVATOR, INHIBITOR
作用メカニズム
Dipeptidyl peptidase IV inhibitor
製品の性質
ALogP
0.9
名前と識別子
異性体SMILES
C1C[C@H](N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N
PubChem CID
6918537
分子量
303.4

詳細データ

関連ターゲット(人間)
DPP4 Tclin Dipeptidyl peptidase 4 (36 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
DPP8 Tchem Dipeptidyl peptidase 8 (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
DPP9 Tchem Dipeptidyl peptidase 9 (12 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
証明書(CoA、COO、BSE/TSEと分析図)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

1 results found

Lot NumberCertificate Type日付商品
C2310997C2310997Certificate of AnalysisOct 12, 2026 V408745
化学的性質と物理的性質
溶解度Solubility (25°C) In vitro DMSO: 50 mg/mL (61.6 mM);    
安全と危険(GHS)
危険表示

H413:May cause long lasting harmful effects to aquatic life

注意表示

P273:Avoid release to the environment.

P501:Dispose of contents/container to an approved waste disposal plant.

よくある質問と記事
Citations of This Product
ソリューション計算機
レビュー

顧客レビュー

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.